HUMAN NON-HODGKINS-LYMPHOMAS OVEREXPRESS A WILD-TYPE FORM OF P53 WHICH IS A FUNCTIONAL TRANSCRIPTIONAL ACTIVATOR OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21
R. Maestro et al., HUMAN NON-HODGKINS-LYMPHOMAS OVEREXPRESS A WILD-TYPE FORM OF P53 WHICH IS A FUNCTIONAL TRANSCRIPTIONAL ACTIVATOR OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21, Blood, 89(7), 1997, pp. 2523-2528
A large fraction of non-Hodgkin's lymphomas (NHLs) accumulate a wild-t
ype form of the p53 tumor suppressor protein at the nuclear level. In
normal cells, p53 induction is associated with a temporary cell growth
arrest at the G1-S boundary of the cell cycle. This activity of p53 a
s a G1 checkpoint molecule is strictly dependent on its ability to ind
uce the transcription of the inhibitor of the cyclin dependent kinase,
p21. To verify the functionality of the wild-type p53 protein accumul
ated in NHL cells, 70 cases were comparatively analyzed for p53 and p2
1 expression and status of the respective genes. Overexpression of the
wt p53 protein was associated with the accumulation of p21, indicatin
g that p53 is functional with respect to p21 induction in these tumors
. The coaccumulation of p53 with Ki-67 antigen indicates that wt p53-p
ositive cells and p21-positive cells, as well, are actively proliferat
ive elements, supporting the notion that p53-induced, p21-mediated gro
wth arrest is somehow overridden in NHL cells. No p21 mutation or part
icular allele variant was shown to correlate with p21 protein accumula
tion, thus excluding a role for p21 structural abnormalities. Taken to
gether, our data suggest the existence in NHL of a peculiar mechanism
of functional inactivation of the p53 G1 checkpoint pathway occurring
downstream of the CDK inhibitor p21. (C) 1997 by The American Society
of Hematology.